Everolimus

Active ingredient

Everolimus

Therapeutic group

Antineoplastic agent, protein kinase inhibitor

Pharmaceutical form

Tablets

Strengh

2,5 mg / 5 mg / 10 mg

Reference product

Afinitor

BIOEQUIVALENCE

Yes (EU)

Our generics are developed and manufactured under European quality standards

Ready to meet our team?